ABSTRACT
amastigotes than in animals infected with promastigotes ( Fig 1C) . Indeed, the signal in 80 the spleen and leg of the animals infected with promastigotes was below the detection 81 limit (Fig. 1C) proof of concept experiment to validate it as a whole-animal imaging system to study anticipated, the short miltefosine treatment was sufficient to significantly decrease the 99 bioluminescent signal in the ROIs defined for the liver and spleen (Fig. 2C ).
100
Amphotericin B was not as effective, although a statistically significant difference was 101 still obtained in the spleen when compared to the untreated animals. Similar results
102
were observed when the parasite burden was determined by the limiting dilution method 103 (Fig. 2D) . However, parasites were still detected in animals whose bioluminescent 104 6 signal was bellow background levels ( Fig. 2D) . Therefore, despite lower sensitiveness, 105 whole-animal bioluminescence imaging enabled the determination of the effectiveness 106 of different treatments in reducing spleen and liver parasite burdens.
107
We further evaluated the correlation between the two techniques used to determine 108 parasite burdens in the liver and the spleen (Fig. 3) We thank Carla Oliveira from i3S for the support with the statistical analysis. 
